Split History
ETFs Holding BLUE »    BLUE Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ß-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD. According to our BLUE split history records, bluebird bio has had 1 split.
BLUE split history picture
bluebird bio (BLUE) has 1 split in our BLUE split history database. The split for BLUE took place on November 05, 2021. This was a 1544 for 1000 split, meaning for each 1000 shares of BLUE owned pre-split, the shareholder now owned 1544 shares. For example, a 1000 share position pre-split, became a 1544 share position following the split.

When a company such as bluebird bio splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the BLUE split history from start to finish, an original position size of 1000 shares would have turned into 1544 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into bluebird bio shares, starting with a $10,000 purchase of BLUE, presented on a split-history-adjusted basis factoring in the complete BLUE split history. BLUE split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/20/2013
End date: 09/27/2022
Start price/share: $16.90
End price/share: $5.45
Dividends collected/share: $0.00
Total return: -67.75%
Average Annual Total Return: -11.48%
Starting investment: $10,000.00
Ending investment: $3,226.40
Years: 9.28
Date Ratio
11/05/20211544 for 1000
BLUE is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

BMRA Split History
BMY Split History
BNTC Split History
BOLT Split History
BONE Split History
BOTA Split History
BPAX Split History
BPMX Split History
BPTH Split History
BRLI Split History

Also explore: BLUE shares outstanding history

Email EnvelopeFree BLUE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Avenue Therapeutics, Inc. (ATXI)
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

BLUE Insider Buying

BLUE Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.